Using an excitable substrate and only 10μg of antibodies, the Liquid Brain® performs single-shot classification of antibody developability risks, demonstrated through case studies matching the combined predictive capability of 12 biophysical assays across 135 clinical-stage antibodies. In another customer study, it identified outliers in 70 VHH - Fcs fragments with >80% accuracy using first-principle dimensionality reduction and unsupervised clustering.
Our dataset of risk scores for clinical… See the full description on the dataset page:
https://huggingface.co/datasets/apoha/antibody_jain_vibescore.
